HIV vaccine vCP1452

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHIV vaccine vCP1452
Drug Alias NameALVAC-HIV vCP1452vCP-1452
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTrinidad and TobagoPuerto Rico +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi PasteurNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A